Clinical Governance 

​

For GLP-1 Medication Services & Telehealth Delivery

1. Purpose

This policy sets out the framework for clinical governance within WLO Ltd (The SkinnyJab)] ensuring the highest standards of patient safety, clinical effectiveness, and accountability in the delivery of GLP-1 medication via tele-health. It ensures compliance with national healthcare standards and builds public trust in our digital healthcare service.

2. Scope

This policy applies to all healthcare professionals, clinicians, administrators, and contracted partners involved in the prescribing, dispensing, or support of GLP-1 medications (e.g., tirzepatide,semaglutide, liraglutide) delivered through telehealth platforms.

3. Principles of Clinical Governance

A. Patient Safety

• Robust Screening: All patients are assessed through a detailed medical questionnaire reviewed by a licensed clinician before medication is prescribed.

• Contraindications Checked: Every prescription follows clinical protocols to rule out contraindications (e.g., thyroid cancer risk, pancreatitis, pregnancy).

• Incident Reporting: All clinical incidents, near misses, and adverse reactions are documented, reviewed, and escalated appropriately.

B. Clinical Effectiveness

• Evidence-Based Protocols: All prescribing and weight management practices align with current NICE/NHS/FDA clinical guidelines and research on GLP-1 therapies.

• Regular Audits: Monthly audits are conducted to review clinical outcomes, prescribing practices, and treatment efficacy.

• Outcome Monitoring: Patients are tracked using key metrics (weight, side effects, quality of life, psychological well-being).

C. Information Governance

• Data Protection Compliance: Fully compliant with GDPR/HIPAA. All telehealth communications are encrypted and hosted on secure platforms.

• Confidentiality: Staff are trained in data security and patient confidentiality as a condition of employment.

D. Clinical Audit

• Routine audits include:

  • Prescribing trends and appropriateness

  • Patient progress and satisfaction

  • Compliance with documentation standards

  • Review of adverse event logs

E. Staffing & Training

• Only qualified clinicians with appropriate licenses and telehealth training are permitted to prescribe.

• Mandatory training includes:

  • GLP-1 pharmacology and patient education

  • Telehealth communication and digital tools

  • Safeguarding and escalation procedures

  • Recognising signs of disordered eating or psychological distress

F. Patient Experience & Engagement

• Patients receive:

  • Informed consent materials before treatment begins

  • Clear written and verbal instructions on GLP-1 usage

  • Regular check-ins (automated or clinician-led)

  • Access to support for side effects, mental health, and diet/lifestyle changes

• Feedback Loop: A formal mechanism is in place to collect and act on patient feedback, including complaints, testimonials, and survey data.

G. Risk Management

• Risk registers are maintained and reviewed quarterly.

• Clinical escalation pathways are clearly defined for:

  • Adverse drug reactions

  • Safeguarding concerns

  • Escalation to in-person care (if needed)

H. Telehealth-Specific Considerations

• Verification of Identity: All patients must provide valid ID prior to treatment.

• Remote Consultation Protocols:

  • Clear documentation of consultation notes

  • Visual/video assessment protocols when required

• Technology Standards:

  • All platforms must be secure, compliant, and regularly updated.

  • Downtime protocols and data recovery plans are in place.

4. Clinical Governance Team & Oversight

• Clinical Lead/Medical Director: Oversees all aspects of clinical governance, reviews audits, and leads quality improvement.

• Governance Committee: Meets quarterly to assess outcomes, review incidents, and update policies as needed.

• Accountability Chain: Every clinician is accountable to a lead prescriber/clinical supervisor.

5. Policy Review

This policy is reviewed annually or when significant regulatory or service model changes occur.